Circulating small extracellular vesicles activate pancreatic stellate cells and impair glucose-stimulated insulin secretion during MASLD

Metabolic dysfunction-associated steatotic liver disease (MASLD) and type 2 diabetes (T2D) are coexisting conditions that synergistically worsen hepatic and systemic outcomes. Circulating small extracellular vesicles (sEV) elicit diverse cellular responses; however, their potential to impair insulin secretion during MASLD progression remains unclear. We investigated the role of MASLD-associated sEV in the activation of pancreatic stellate cells (PSCs) and the impact on insulin secretion, shedding light on the inter-organ crosstalk in metabolic diseases. C57BL6 male mice were fed a chow (CHD) or a choline-deficient, amino acid defined high-fat diet (CDAAHFD) for 3 or 9 weeks. Metabolic profiles, morphological and functional alterations in hepatic and pancreatic tissues were assessed. Plasma and circulating sEV were characterized by lipidomics and the sEV effects on PSCs activation and glucose-stimulated insulin secretion (GSIS) in pancreatic islets were assessed. Lean mice received single or repeated injections of MASLD-associated circulating sEV to examine their impact on liver and pancreas. Plasma sEV from healthy or individuals with MASLD were characterized by lipidomics, and their ability to activate human PSCs was tested. The PSCs-derived secretome was analysed by proteomics and applied to human stem cell-derived islets (SC-islets). Mice fed a CDAAHFD diet exhibited liver injury, islet inflammation, PSC activation, and increased circulating sEV enriched in reactive lipid species. In vitro, sEV from CDAAHFD-fed mice were efficiently internalized by PSCs and features of activation were found. Likewise, sEV from CDAAHFD-fed mice were internalized by pancreatic islets where they reduced GSIS. After a single in vivo injection, sEV were internalized by macrophages in both liver and pancreas, while repeated injections recruited macrophages and PSCs into pancreatic islets and reduced ex vivo GSIS. Individuals with MASLD also showed elevated plasma sEV levels which activated human PSCs in culture. Under these conditions, conditioned media from activated PSCs impaired GSIS in SC-islets. This study offers new insights into the role of MASLD-associated circulating sEV in regulating hepatic and pancreatic physiology, highlighting their contribution to PSC activation and GSIS impairment. These findings reveal a potential mechanistic between MASLD and the development of T2D.

Authors

Institutions

Publication Details

Journal
Cell Communication and Signaling
Published
2026-11-12
DOI
https://doi.org/10.1186/s12964-026-03351-8
Primary Topic
Pancreatic function and diabetes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Circulating small extracellular vesicles activate pancreatic stellate cells and impair glucose-stimulated insulin secretion during MASLD

Rosa F. Hwang, Carmen Carnicero, Jose Antonio Tapia, Antonio González et al.
Cell Communication and Signaling
Pancreatic function and diabetes
article

Circulating small extracellular vesicles activate pancreatic stellate cells and impair glucose-stimulated insulin secretion during MASLD

Rosa F. Hwang, Carmen Carnicero, Jose Antonio Tapia, Antonio González, Angela Martinez Valverde, Irma García‐Martinez, Rubén Francés, Francisco Javier Rupérez, Rosa Alén, Manuel Izquierdo, Alberto Bartolomé, Constanza Fernández-Hernández, R. Aller, Sofia Romeo Rodríguez, Sebastián Mas, Marta González‐Matesanz, Antonia García, Víctor Arroyo
article en

Abstract

Metabolic dysfunction-associated steatotic liver disease (MASLD) and type 2 diabetes (T2D) are coexisting conditions that synergistically worsen hepatic and systemic outcomes. Circulating small extracellular vesicles (sEV) elicit diverse cellular responses; however, their potential to impair insulin secretion during MASLD progression remains unclear. We investigated the role of MASLD-associated sEV in the activation of pancreatic stellate cells (PSCs) and the impact on insulin secretion, shedding light on the inter-organ crosstalk in metabolic diseases. C57BL6 male mice were fed a chow (CHD) or a choline-deficient, amino acid defined high-fat diet (CDAAHFD) for 3 or 9 weeks. Metabolic profiles, morphological and functional alterations in hepatic and pancreatic tissues were assessed. Plasma and circulating sEV were characterized by lipidomics and the sEV effects on PSCs activation and glucose-stimulated insulin secretion (GSIS) in pancreatic islets were assessed. Lean mice received single or repeated injections of MASLD-associated circulating sEV to examine their impact on liver and pancreas. Plasma sEV from healthy or individuals with MASLD were characterized by lipidomics, and their ability to activate human PSCs was tested. The PSCs-derived secretome was analysed by proteomics and applied to human stem cell-derived islets (SC-islets). Mice fed a CDAAHFD diet exhibited liver injury, islet inflammation, PSC activation, and increased circulating sEV enriched in reactive lipid species. In vitro, sEV from CDAAHFD-fed mice were efficiently internalized by PSCs and features of activation were found. Likewise, sEV from CDAAHFD-fed mice were internalized by pancreatic islets where they reduced GSIS. After a single in vivo injection, sEV were internalized by macrophages in both liver and pancreas, while repeated injections recruited macrophages and PSCs into pancreatic islets and reduced ex vivo GSIS. Individuals with MASLD also showed elevated plasma sEV levels which activated human PSCs in culture. Under these conditions, conditioned media from activated PSCs impaired GSIS in SC-islets. This study offers new insights into the role of MASLD-associated circulating sEV in regulating hepatic and pancreatic physiology, highlighting their contribution to PSC activation and GSIS impairment. These findings reveal a potential mechanistic between MASLD and the development of T2D.

Cell Communication and Signaling
Universidad de Valladolid (ES), Universitat de Miguel Hernández d'Elx (ES), Universidad San Pablo CEU (ES), The University of Texas MD Anderson Cancer Center (US), Consejo Superior de Investigaciones Científicas (ES), Instituto de Salud Carlos III (ES), Instituto de Investigaciones Biomédicas Sols-Morreale (ES), Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas (ES), Centro de Investigación Biomédica en Red (ES), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (ES), Hospital Clínico Universitario de Valladolid (ES), Instituto de Investigación Sanitaria Fundación Jiménez Díaz (ES), Centro de Investigación Biomédica en Red Enfermedades Infecciosas (ES), Universidad de Extremadura (ES)
Good health and well-being
Pancreatic function and diabetes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon